Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation

Aim We carried out a clinicopathological analysis of cases presenting with interstitial fibrosis and tubular atrophy (IF/TA) after renal transplantation in an attempt to clarify the mechanisms underlying the development and prognostic significance of IF/TA. Methods IF/TA was diagnosed in 35 renal al...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology (Carlton, Vic.) Vic.), 2016-07, Vol.21 (S1), p.26-30
Hauptverfasser: Shimizu, Tomokazu, Toma, Hiroshi, Hayakawa, Nozomi, Shibahara, Rumi, Ishiyama, Ryou, Hayashida, Akihiro, Fujimori, Daiji, Tsunoyama, Kuniko, Ikezawa, Eri, Kitajima, Shoji, Iida, Shoichi, Ishida, Hideki, Tanabe, Kazunari, Honda, Kazuho, Koike, Junki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue S1
container_start_page 26
container_title Nephrology (Carlton, Vic.)
container_volume 21
creator Shimizu, Tomokazu
Toma, Hiroshi
Hayakawa, Nozomi
Shibahara, Rumi
Ishiyama, Ryou
Hayashida, Akihiro
Fujimori, Daiji
Tsunoyama, Kuniko
Ikezawa, Eri
Kitajima, Shoji
Iida, Shoichi
Ishida, Hideki
Tanabe, Kazunari
Honda, Kazuho
Koike, Junki
description Aim We carried out a clinicopathological analysis of cases presenting with interstitial fibrosis and tubular atrophy (IF/TA) after renal transplantation in an attempt to clarify the mechanisms underlying the development and prognostic significance of IF/TA. Methods IF/TA was diagnosed in 35 renal allograft biopsy specimens (BS) obtained from 35 renal transplant recipients under follow up at the Department of Transplant Surgery, Kidney Center, Toda Chuo General Hospital, between January 2014 and March 2015. Results IF/TA was diagnosed at a median of 39.9 months after the transplantation. Among the 35 patients with IF/TA, 19 (54%) had a history of acute rejection. Among the 35 BS showing evidence of IF/TA, the IF/TA was grade I in 25, grade II in 9, and grade III in 1. Arteriosclerosis of the middle‐sized arteries was observed in 30 BS (86%). We then classified the 35 BS showing evidence of IF/TA according to their overall histopathological features, as follows; IF/TA alone (6 BS; 17%), IF/TA + medullary ray injury (12 BS; 34%), and IF/TA + rejection (12 BS; 34%). Loss of the renal allograft occurred during the observation period in one of the patients (3%). Of the remaining patients with functioning grafts, deterioration of the renal allograft function after the biopsies occurred in 15 patients (43%). Conclusions The results of our study suggests that rejection contributes to IF/TA in 30–40% of cases, medullary ray injury in 30–40% of cases, and nonspecific injury in 20% of cases. IF/TA contributes significantly to deterioration of renal allograft function.
doi_str_mv 10.1111/nep.12766
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1799561864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1799561864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3986-e006bb3e333b4a1ecc44fa522bd7590401b7271ed2cbd077112634d4a888b2343</originalsourceid><addsrcrecordid>eNp1kMtO3DAYhS1UVCh00ReosiyLgG-x42U74tKCuEhUldhYvxOnuHiSYDsqeXs8zMAOb2zZ3zn6_SH0heBDktdRb8dDQqUQW2iXcI5LIpX8kM-M4rJiVb2DPsX4D2MiqSAf0Q4VSlIl1C4KC-9614AvoG-LEdL94Ie_mwvwc7SxGLrC9cmGmFxy-aFzJgzRxZdImszkIRSQwjDez0UDqwh0mS8eXNvbuUgB-jh66BMkN_T7aLsDH-3nzb6Hfp8c3y7Oyour05-L7xdlw1QtSouxMIZZxpjhQGzTcN5BRalpZaUwx8RIKoltaWNaLCUhVDDecqjr2lDG2R76tu4dw_A42Zj00sXG-jyIHaaosyRVCVKLFXqwRpv8sRhsp8fglhBmTbBeKdZZsX5RnNmvm9rJLG37Rr46zcDRGvjvvJ3fb9KXx9evleU64WKyT28JCA9aSCYr_efyVP9Qd-z87EbpX-wZ0qGWug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1799561864</pqid></control><display><type>article</type><title>Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Shimizu, Tomokazu ; Toma, Hiroshi ; Hayakawa, Nozomi ; Shibahara, Rumi ; Ishiyama, Ryou ; Hayashida, Akihiro ; Fujimori, Daiji ; Tsunoyama, Kuniko ; Ikezawa, Eri ; Kitajima, Shoji ; Iida, Shoichi ; Ishida, Hideki ; Tanabe, Kazunari ; Honda, Kazuho ; Koike, Junki</creator><creatorcontrib>Shimizu, Tomokazu ; Toma, Hiroshi ; Hayakawa, Nozomi ; Shibahara, Rumi ; Ishiyama, Ryou ; Hayashida, Akihiro ; Fujimori, Daiji ; Tsunoyama, Kuniko ; Ikezawa, Eri ; Kitajima, Shoji ; Iida, Shoichi ; Ishida, Hideki ; Tanabe, Kazunari ; Honda, Kazuho ; Koike, Junki</creatorcontrib><description>Aim We carried out a clinicopathological analysis of cases presenting with interstitial fibrosis and tubular atrophy (IF/TA) after renal transplantation in an attempt to clarify the mechanisms underlying the development and prognostic significance of IF/TA. Methods IF/TA was diagnosed in 35 renal allograft biopsy specimens (BS) obtained from 35 renal transplant recipients under follow up at the Department of Transplant Surgery, Kidney Center, Toda Chuo General Hospital, between January 2014 and March 2015. Results IF/TA was diagnosed at a median of 39.9 months after the transplantation. Among the 35 patients with IF/TA, 19 (54%) had a history of acute rejection. Among the 35 BS showing evidence of IF/TA, the IF/TA was grade I in 25, grade II in 9, and grade III in 1. Arteriosclerosis of the middle‐sized arteries was observed in 30 BS (86%). We then classified the 35 BS showing evidence of IF/TA according to their overall histopathological features, as follows; IF/TA alone (6 BS; 17%), IF/TA + medullary ray injury (12 BS; 34%), and IF/TA + rejection (12 BS; 34%). Loss of the renal allograft occurred during the observation period in one of the patients (3%). Of the remaining patients with functioning grafts, deterioration of the renal allograft function after the biopsies occurred in 15 patients (43%). Conclusions The results of our study suggests that rejection contributes to IF/TA in 30–40% of cases, medullary ray injury in 30–40% of cases, and nonspecific injury in 20% of cases. IF/TA contributes significantly to deterioration of renal allograft function.</description><identifier>ISSN: 1320-5358</identifier><identifier>EISSN: 1440-1797</identifier><identifier>DOI: 10.1111/nep.12766</identifier><identifier>PMID: 26972969</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Allografts ; Atrophy ; Biopsy ; calcineurin inhibitor arteriolopathy ; Disease Progression ; Female ; Fibrosis ; Graft Rejection - etiology ; Graft Rejection - pathology ; Graft Rejection - physiopathology ; Graft Survival ; Hospitals, General ; Humans ; interstitial fibrosis and tubular atrophy ; Japan ; Kidney Diseases - etiology ; Kidney Diseases - pathology ; Kidney Diseases - physiopathology ; Kidney Function Tests ; kidney transplantation ; Kidney Transplantation - adverse effects ; Kidney Tubules - pathology ; Kidney Tubules - physiopathology ; Male ; medullary ray injury ; Middle Aged ; rejection ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; Young Adult</subject><ispartof>Nephrology (Carlton, Vic.), 2016-07, Vol.21 (S1), p.26-30</ispartof><rights>2016 Asian Pacific Society of Nephrology</rights><rights>2016 Asian Pacific Society of Nephrology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3986-e006bb3e333b4a1ecc44fa522bd7590401b7271ed2cbd077112634d4a888b2343</citedby><cites>FETCH-LOGICAL-c3986-e006bb3e333b4a1ecc44fa522bd7590401b7271ed2cbd077112634d4a888b2343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fnep.12766$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fnep.12766$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26972969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimizu, Tomokazu</creatorcontrib><creatorcontrib>Toma, Hiroshi</creatorcontrib><creatorcontrib>Hayakawa, Nozomi</creatorcontrib><creatorcontrib>Shibahara, Rumi</creatorcontrib><creatorcontrib>Ishiyama, Ryou</creatorcontrib><creatorcontrib>Hayashida, Akihiro</creatorcontrib><creatorcontrib>Fujimori, Daiji</creatorcontrib><creatorcontrib>Tsunoyama, Kuniko</creatorcontrib><creatorcontrib>Ikezawa, Eri</creatorcontrib><creatorcontrib>Kitajima, Shoji</creatorcontrib><creatorcontrib>Iida, Shoichi</creatorcontrib><creatorcontrib>Ishida, Hideki</creatorcontrib><creatorcontrib>Tanabe, Kazunari</creatorcontrib><creatorcontrib>Honda, Kazuho</creatorcontrib><creatorcontrib>Koike, Junki</creatorcontrib><title>Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation</title><title>Nephrology (Carlton, Vic.)</title><addtitle>Nephrology</addtitle><description>Aim We carried out a clinicopathological analysis of cases presenting with interstitial fibrosis and tubular atrophy (IF/TA) after renal transplantation in an attempt to clarify the mechanisms underlying the development and prognostic significance of IF/TA. Methods IF/TA was diagnosed in 35 renal allograft biopsy specimens (BS) obtained from 35 renal transplant recipients under follow up at the Department of Transplant Surgery, Kidney Center, Toda Chuo General Hospital, between January 2014 and March 2015. Results IF/TA was diagnosed at a median of 39.9 months after the transplantation. Among the 35 patients with IF/TA, 19 (54%) had a history of acute rejection. Among the 35 BS showing evidence of IF/TA, the IF/TA was grade I in 25, grade II in 9, and grade III in 1. Arteriosclerosis of the middle‐sized arteries was observed in 30 BS (86%). We then classified the 35 BS showing evidence of IF/TA according to their overall histopathological features, as follows; IF/TA alone (6 BS; 17%), IF/TA + medullary ray injury (12 BS; 34%), and IF/TA + rejection (12 BS; 34%). Loss of the renal allograft occurred during the observation period in one of the patients (3%). Of the remaining patients with functioning grafts, deterioration of the renal allograft function after the biopsies occurred in 15 patients (43%). Conclusions The results of our study suggests that rejection contributes to IF/TA in 30–40% of cases, medullary ray injury in 30–40% of cases, and nonspecific injury in 20% of cases. IF/TA contributes significantly to deterioration of renal allograft function.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Allografts</subject><subject>Atrophy</subject><subject>Biopsy</subject><subject>calcineurin inhibitor arteriolopathy</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Graft Rejection - etiology</subject><subject>Graft Rejection - pathology</subject><subject>Graft Rejection - physiopathology</subject><subject>Graft Survival</subject><subject>Hospitals, General</subject><subject>Humans</subject><subject>interstitial fibrosis and tubular atrophy</subject><subject>Japan</subject><subject>Kidney Diseases - etiology</subject><subject>Kidney Diseases - pathology</subject><subject>Kidney Diseases - physiopathology</subject><subject>Kidney Function Tests</subject><subject>kidney transplantation</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Tubules - pathology</subject><subject>Kidney Tubules - physiopathology</subject><subject>Male</subject><subject>medullary ray injury</subject><subject>Middle Aged</subject><subject>rejection</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>1320-5358</issn><issn>1440-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtO3DAYhS1UVCh00ReosiyLgG-x42U74tKCuEhUldhYvxOnuHiSYDsqeXs8zMAOb2zZ3zn6_SH0heBDktdRb8dDQqUQW2iXcI5LIpX8kM-M4rJiVb2DPsX4D2MiqSAf0Q4VSlIl1C4KC-9614AvoG-LEdL94Ie_mwvwc7SxGLrC9cmGmFxy-aFzJgzRxZdImszkIRSQwjDez0UDqwh0mS8eXNvbuUgB-jh66BMkN_T7aLsDH-3nzb6Hfp8c3y7Oyour05-L7xdlw1QtSouxMIZZxpjhQGzTcN5BRalpZaUwx8RIKoltaWNaLCUhVDDecqjr2lDG2R76tu4dw_A42Zj00sXG-jyIHaaosyRVCVKLFXqwRpv8sRhsp8fglhBmTbBeKdZZsX5RnNmvm9rJLG37Rr46zcDRGvjvvJ3fb9KXx9evleU64WKyT28JCA9aSCYr_efyVP9Qd-z87EbpX-wZ0qGWug</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Shimizu, Tomokazu</creator><creator>Toma, Hiroshi</creator><creator>Hayakawa, Nozomi</creator><creator>Shibahara, Rumi</creator><creator>Ishiyama, Ryou</creator><creator>Hayashida, Akihiro</creator><creator>Fujimori, Daiji</creator><creator>Tsunoyama, Kuniko</creator><creator>Ikezawa, Eri</creator><creator>Kitajima, Shoji</creator><creator>Iida, Shoichi</creator><creator>Ishida, Hideki</creator><creator>Tanabe, Kazunari</creator><creator>Honda, Kazuho</creator><creator>Koike, Junki</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201607</creationdate><title>Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation</title><author>Shimizu, Tomokazu ; Toma, Hiroshi ; Hayakawa, Nozomi ; Shibahara, Rumi ; Ishiyama, Ryou ; Hayashida, Akihiro ; Fujimori, Daiji ; Tsunoyama, Kuniko ; Ikezawa, Eri ; Kitajima, Shoji ; Iida, Shoichi ; Ishida, Hideki ; Tanabe, Kazunari ; Honda, Kazuho ; Koike, Junki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3986-e006bb3e333b4a1ecc44fa522bd7590401b7271ed2cbd077112634d4a888b2343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Allografts</topic><topic>Atrophy</topic><topic>Biopsy</topic><topic>calcineurin inhibitor arteriolopathy</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Graft Rejection - etiology</topic><topic>Graft Rejection - pathology</topic><topic>Graft Rejection - physiopathology</topic><topic>Graft Survival</topic><topic>Hospitals, General</topic><topic>Humans</topic><topic>interstitial fibrosis and tubular atrophy</topic><topic>Japan</topic><topic>Kidney Diseases - etiology</topic><topic>Kidney Diseases - pathology</topic><topic>Kidney Diseases - physiopathology</topic><topic>Kidney Function Tests</topic><topic>kidney transplantation</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Tubules - pathology</topic><topic>Kidney Tubules - physiopathology</topic><topic>Male</topic><topic>medullary ray injury</topic><topic>Middle Aged</topic><topic>rejection</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimizu, Tomokazu</creatorcontrib><creatorcontrib>Toma, Hiroshi</creatorcontrib><creatorcontrib>Hayakawa, Nozomi</creatorcontrib><creatorcontrib>Shibahara, Rumi</creatorcontrib><creatorcontrib>Ishiyama, Ryou</creatorcontrib><creatorcontrib>Hayashida, Akihiro</creatorcontrib><creatorcontrib>Fujimori, Daiji</creatorcontrib><creatorcontrib>Tsunoyama, Kuniko</creatorcontrib><creatorcontrib>Ikezawa, Eri</creatorcontrib><creatorcontrib>Kitajima, Shoji</creatorcontrib><creatorcontrib>Iida, Shoichi</creatorcontrib><creatorcontrib>Ishida, Hideki</creatorcontrib><creatorcontrib>Tanabe, Kazunari</creatorcontrib><creatorcontrib>Honda, Kazuho</creatorcontrib><creatorcontrib>Koike, Junki</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimizu, Tomokazu</au><au>Toma, Hiroshi</au><au>Hayakawa, Nozomi</au><au>Shibahara, Rumi</au><au>Ishiyama, Ryou</au><au>Hayashida, Akihiro</au><au>Fujimori, Daiji</au><au>Tsunoyama, Kuniko</au><au>Ikezawa, Eri</au><au>Kitajima, Shoji</au><au>Iida, Shoichi</au><au>Ishida, Hideki</au><au>Tanabe, Kazunari</au><au>Honda, Kazuho</au><au>Koike, Junki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation</atitle><jtitle>Nephrology (Carlton, Vic.)</jtitle><addtitle>Nephrology</addtitle><date>2016-07</date><risdate>2016</risdate><volume>21</volume><issue>S1</issue><spage>26</spage><epage>30</epage><pages>26-30</pages><issn>1320-5358</issn><eissn>1440-1797</eissn><abstract>Aim We carried out a clinicopathological analysis of cases presenting with interstitial fibrosis and tubular atrophy (IF/TA) after renal transplantation in an attempt to clarify the mechanisms underlying the development and prognostic significance of IF/TA. Methods IF/TA was diagnosed in 35 renal allograft biopsy specimens (BS) obtained from 35 renal transplant recipients under follow up at the Department of Transplant Surgery, Kidney Center, Toda Chuo General Hospital, between January 2014 and March 2015. Results IF/TA was diagnosed at a median of 39.9 months after the transplantation. Among the 35 patients with IF/TA, 19 (54%) had a history of acute rejection. Among the 35 BS showing evidence of IF/TA, the IF/TA was grade I in 25, grade II in 9, and grade III in 1. Arteriosclerosis of the middle‐sized arteries was observed in 30 BS (86%). We then classified the 35 BS showing evidence of IF/TA according to their overall histopathological features, as follows; IF/TA alone (6 BS; 17%), IF/TA + medullary ray injury (12 BS; 34%), and IF/TA + rejection (12 BS; 34%). Loss of the renal allograft occurred during the observation period in one of the patients (3%). Of the remaining patients with functioning grafts, deterioration of the renal allograft function after the biopsies occurred in 15 patients (43%). Conclusions The results of our study suggests that rejection contributes to IF/TA in 30–40% of cases, medullary ray injury in 30–40% of cases, and nonspecific injury in 20% of cases. IF/TA contributes significantly to deterioration of renal allograft function.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>26972969</pmid><doi>10.1111/nep.12766</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1320-5358
ispartof Nephrology (Carlton, Vic.), 2016-07, Vol.21 (S1), p.26-30
issn 1320-5358
1440-1797
language eng
recordid cdi_proquest_miscellaneous_1799561864
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
Aged
Allografts
Atrophy
Biopsy
calcineurin inhibitor arteriolopathy
Disease Progression
Female
Fibrosis
Graft Rejection - etiology
Graft Rejection - pathology
Graft Rejection - physiopathology
Graft Survival
Hospitals, General
Humans
interstitial fibrosis and tubular atrophy
Japan
Kidney Diseases - etiology
Kidney Diseases - pathology
Kidney Diseases - physiopathology
Kidney Function Tests
kidney transplantation
Kidney Transplantation - adverse effects
Kidney Tubules - pathology
Kidney Tubules - physiopathology
Male
medullary ray injury
Middle Aged
rejection
Retrospective Studies
Risk Factors
Severity of Illness Index
Time Factors
Treatment Outcome
Young Adult
title Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A23%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20pathological%20analyses%20of%20interstitial%20fibrosis%20and%20tubular%20atrophy%20cases%20after%20kidney%20transplantation&rft.jtitle=Nephrology%20(Carlton,%20Vic.)&rft.au=Shimizu,%20Tomokazu&rft.date=2016-07&rft.volume=21&rft.issue=S1&rft.spage=26&rft.epage=30&rft.pages=26-30&rft.issn=1320-5358&rft.eissn=1440-1797&rft_id=info:doi/10.1111/nep.12766&rft_dat=%3Cproquest_cross%3E1799561864%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1799561864&rft_id=info:pmid/26972969&rfr_iscdi=true